Plastic vs Biodegradable Pancreatic Stent in Post-ERCP Pancreatitis Prevention

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Multiple risk factors have been linked with post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP); therefore, it is critical to follow strategies to reduce associated risk, morbidity, and mortality. However, there are also factors, such as pancreatic duct stenting, which have shown evidence of PEP prevention. The investigators pursue to compare plastic vs biodegradable pancreatic stents in the prevention of PEP.
Epistemonikos ID: 6daebc66de4599d48078ccb34b010ca112de5056
First added on: May 13, 2024